A number of firms have modified their ratings and price targets on shares of UnitedHealth Group (NYSE: UNH) recently:
- 6/1/2026 – UnitedHealth Group had its price target raised by Truist Financial Corporation from $395.00 to $440.00. They now have a “buy” rating on the stock.
- 5/27/2026 – UnitedHealth Group was given a new $492.00 price target by HC Wainwright.
- 5/27/2026 – UnitedHealth Group had its price target raised by Sanford C. Bernstein from $444.00 to $492.00. They now have an “outperform” rating on the stock.
- 5/26/2026 – UnitedHealth Group had its price target raised by Barclays PLC from $373.00 to $429.00. They now have an “overweight” rating on the stock.
- 5/22/2026 – UnitedHealth Group had its price target raised by UBS Group AG from $410.00 to $460.00. They now have a “buy” rating on the stock.
- 5/20/2026 – UnitedHealth Group had its price target raised by Mizuho from $410.00 to $440.00. They now have an “outperform” rating on the stock.
- 5/7/2026 – UnitedHealth Group was upgraded by Weiss Ratings from “sell (d+)” to “hold (c-)”.
- 4/28/2026 – UnitedHealth Group had its price target raised by JPMorgan Chase & Co. from $389.00 to $420.00. They now have an “overweight” rating on the stock.
- 4/27/2026 – UnitedHealth Group was upgraded by Erste Group Bank AG from “hold” to “buy”.
- 4/23/2026 – UnitedHealth Group had its price target raised by TD Cowen from $311.00 to $337.00. They now have a “hold” rating on the stock.
- 4/22/2026 – UnitedHealth Group had its price target raised by Morgan Stanley from $375.00 to $395.00. They now have an “overweight” rating on the stock.
- 4/22/2026 – UnitedHealth Group had its price target raised by Leerink Partners from $345.00 to $400.00. They now have an “outperform” rating on the stock.
- 4/22/2026 – UnitedHealth Group had its price target raised by Royal Bank Of Canada from $361.00 to $400.00. They now have an “outperform” rating on the stock.
- 4/22/2026 – UnitedHealth Group had its price target raised by Wells Fargo & Company from $370.00 to $397.00. They now have an “overweight” rating on the stock.
- 4/22/2026 – UnitedHealth Group had its price target raised by Oppenheimer Holdings, Inc. from $385.00 to $405.00. They now have an “outperform” rating on the stock.
- 4/22/2026 – UnitedHealth Group had its price target raised by Barclays PLC from $327.00 to $373.00. They now have an “overweight” rating on the stock.
- 4/22/2026 – UnitedHealth Group had its price target raised by Robert W. Baird from $278.00 to $287.00. They now have an “underperform” rating on the stock.
- 4/22/2026 – UnitedHealth Group had its “buy” rating reaffirmed by Truist Financial Corporation. They now have a $395.00 price target on the stock, up from $370.00.
- 4/22/2026 – UnitedHealth Group was upgraded by Argus from “hold” to “buy”. They now have a $400.00 price target on the stock.
- 4/20/2026 – UnitedHealth Group had its price target raised by Jefferies Financial Group Inc. from $340.00 to $373.00. They now have a “buy” rating on the stock.
- 4/7/2026 – UnitedHealth Group had its price target raised by Sanford C. Bernstein from $405.00 to $411.00. They now have an “outperform” rating on the stock.
- 4/7/2026 – UnitedHealth Group was upgraded by HSBC Holdings plc from “reduce” to “hold”. They now have a $300.00 price target on the stock.
Insiders Place Their Bets
In related news, CEO Patrick Hugh Conway sold 800 shares of the stock in a transaction dated Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total value of $284,000.00. Following the sale, the chief executive officer directly owned 17,805 shares of the company’s stock, valued at $6,320,775. This represents a 4.30% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.28% of the stock is owned by company insiders.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- Microsoft Build 2026 Is Really Just One Big AI Stress Test
- Slice of the Pie: Why Yum’s Deal Lifts QSR
- 3 Most Upgraded Stocks Last Month According to MarketBeat
- MongoDB Is the Latest SaaS Apocalypse Victim to Say “Not Today”
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.
